Few Engage in Five Behaviors for Preventing Chronic Disease

Share this content:
Few Engage in Five Behaviors for Preventing Chronic Disease
Few Engage in Five Behaviors for Preventing Chronic Disease

MONDAY, June 6, 2016 (HealthDay News) -- Few U.S. adults engage in all five health-related behaviors recommended for chronic disease prevention, according to a study published online May 26 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

Yong Liu, M.D., from the CDC in Atlanta, and colleagues estimated clustering of five health-related behaviors for chronic disease prevention in each state. Data from the 2013 Behavioral Risk Factor Surveillance System for 395,343 respondents (aged 21 years or older) were used to assess clustering of never smoking, getting regular physical activity, consuming no alcohol or only moderate amounts, maintaining a normal body mass index (BMI), and obtaining daily sufficient sleep.

The researchers found that 81.6 percent of U.S. adults were current nonsmokers; 63.9 percent obtained seven hours or more sleep/day; 63.1 percent reported moderate or no alcohol consumption; 50.4 percent met recommendations for physical activity; and 32.5 percent had a normal BMI. Overall, 1.4, 8.4, 24.3, 35.4, 24.3, and 6.3 percent of respondents engaged in none, one, two, three, four, and five of these behaviors, respectively. The prevalence of engaging in four or five behaviors was highest in the Pacific and Rocky Mountain states, while prevalence was lowest in the southern states and along the Ohio River.

"Collaborative efforts in health care systems, communities, work sites, and schools can promote all five behaviors and produce population-wide changes, especially among the socioeconomically disadvantaged," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »